The GNRSU stock traded at $0.000001 on 27 Feb 2026 during regular market hours on the PNK exchange in the United States, reflecting a -99.99933% intraday move and extremely thin volume (145 shares). The Greenrose Holding Company Inc. (GNRSU) is listed as a small-cap cannabis producer in the Healthcare sector and showed a prior close of $0.15. The abrupt price collapse and the tiny reported market cap ($13.00) signal severe liquidity and quotation issues rather than normal market-driven revaluation. Investors should treat today’s quote as a short-term market microstructure event and read the analysis below for valuation, risks, and a model forecast

Market snapshot for GNRSU stock

GNRSU stock last printed $0.000001 on the PNK exchange in the United States with 145 shares traded today. The stock shows a day low and day high at $0.000001, a previous close of $0.15, and a year high of $0.151.

Trading data show an average price history around $0.15 (50- and 200-day averages) and a market cap reported at $13.00, indicating a quotation near zero and constrained liquidity rather than steady market demand.

What likely drove the GNRSU stock collapse

The immediate driver appears to be severe liquidity mismatch and quotation re-pricing; GNRSU traded only 145 shares today. Thin trading can produce large percentage moves, especially on PNK where order depth is shallow.

Other contributors may include corporate actions, quotation adjustments, or withdrawal of active market makers. There is no confirmed earnings release or regulatory notice tied to this intraday move in the public profile, so the drop should be read as a trading event until further company disclosures arrive.

GNRSU financials and valuation metrics

Key figures show EPS (TTM) 3.10 and an unusual PE TTM ~0.00000032, driven by the extreme price denominator and reported net income figures. Book value per share is $4.30 and cash per share is $0.56, while shares outstanding total 12,853,627.

Balance metrics reveal stress: current ratio 0.21, debt to equity 1.57, and working capital strongly negative (-103,434,000.00). These figures indicate leverage and liquidity strain despite favorable operating margins reported in the TTM metrics.

Liquidity, trading risks and sector context for GNRSU stock

GNRSU operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic and cannabis production. The sector remains volatile and speculative, and small OTC/Pink-listed names can swing on rumors, regulatory signals, or market-maker quotes.

Practical trading risks: negligible average volume (no avgVolume data), wide bid-ask risk, and high inventory days (439.24) suggest inventory build and slow turnover. Traders should expect execution uncertainty and possible quote suspensions.

Meyka AI grade and GNRSU forecast

Meyka AI rates GNRSU with a score out of 100: 67.10 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector and industry performance, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth.

Meyka AI’s forecast model projects $0.00 for GNRSU over the modeled horizon, which compared to the current quote of $0.000001 implies a theoretical downside nearing 100.00%. Forecasts are model-based projections and not guarantees. For more company background visit Greenrose website and the company LinkedIn page.

Price targets and short-term outlook for GNRSU stock

No broker consensus price target is available. Using model scenarios and historical 52-week data, we outline a range: Bear floor $0.000001, Base case $0.01, Bull case $0.15 (prior year high). The base case reflects continued operational recovery and relisting or renewed market interest.

These targets imply extreme percentage moves from today: base case suggests theoretical upside in the order of 1,000,000.00%, illustrating that percentage math on micro-priced names can be misleading. Treat targets as scenario markers, not precise predictions.

Final Thoughts

GNRSU stock printed $0.000001 on 27 Feb 2026 during market hours on PNK, reflecting an acute liquidity and quotation event rather than normal price discovery. The Greenrose Holding Company Inc. shows mixed accounting metrics—positive EPS and book value per share but strained working capital and a low current ratio—creating asymmetric and risky fundamentals for holders. Meyka AI rates the company 67.10/100 (Grade B, HOLD) and flags liquidity and market-quote risk. Meyka AI’s forecast model projects $0.00, essentially a model-driven warning given the current quote of $0.000001, and forecasts are not guarantees. Short-term traders should expect execution risk and possible quote revisions; longer-term investors must seek clear corporate disclosures or material operational improvements before re-entering. For ongoing updates see the company site and our Meyka AI stock page for GNRSU

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.